Related Experiment Videos

Trisomy 11 and other nonrandom trisomies in congenital fibrosarcoma

R Bernstein1, P M Zeltzer, F Lin

  • 1Division of Human Genetics, College of Medicine, University of California, Irvine.

Insights

A study of infant fibrosarcoma revealed abnormal chromosomes, specifically trisomy 11. This finding suggests a potential link between infantile fibrosarcoma and congenital mesoblastic nephroma.

Area of Science:

  • Cytogenetics
  • Pediatric Oncology
  • Developmental Biology

Background:

  • Malignant fibrosarcoma is a rare soft tissue sarcoma.
  • Congenital or infantile fibrosarcoma is a rare subtype.
  • Understanding the genetic basis of these tumors is crucial for diagnosis and treatment.

Observation:

  • Chromosome analysis of a 7-week-old female infant with intraabdominal malignant fibrosarcoma revealed a hyperdiploid karyotype: 50,XX, +der(6)del(6)(p23)add(6)(q11), +8, +10, +11,add(12)(p13).

Findings:

  • Trisomy 11 was identified as a nonrandom primary cytogenetic abnormality in this infantile fibrosarcoma.
  • Trisomy 11 is also a nonrandom chromosomal gain in congenital mesoblastic nephroma.
  • The consistent presence of trisomy 11 in both tumor types suggests a shared genetic mechanism.

Implications:

  • A potential developmental link between infantile fibrosarcoma and congenital mesoblastic nephroma is postulated.
  • Genes on chromosome 11 may play a critical role in the development of these mesenchymal tumors.
  • Further research into chromosome 11's role could lead to novel therapeutic strategies for pediatric soft tissue sarcomas.

Related Concept Videos